Drug. Co. Can't Keep Emails Under Wraps In Valsartan MDL

By Emily Field · January 8, 2021, 10:06 PM EST

A New Jersey federal judge on Friday said that emails sent by Torrent Pharmaceuticals Ltd. to customers in the multidistrict litigation over alleged contamination of the blood pressure drug Valsartan are...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION

Case Number

Court

New Jersey

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

February 14, 2019

Recent Articles By Emily

June 24, 2024
Ark. AG Sues Pharmacy Benefit Managers Over Opioids
May 03, 2024
6 States Strike $270M Opioid Deal With Amneal
April 17, 2024
FDA's Foot-Dragging On Menthol Ban Sparks Frustration
March 26, 2024
Opioid Public Nuisance Claims 'Unique,' Ohio High Court Told
March 25, 2024
What To Watch As Opioid Litigation Goes To Ohio High Court
March 11, 2024
FDA Seeks $7.2B For Fiscal Year 2025
March 07, 2024
Sens. Tell Stores To Get Illegal E-Cigs Off Their Shelves
February 27, 2024
10th Circ. Backs FDA E-Cigarettes Marketing Denial
February 14, 2024
NYC Sues Facebook, Social Media Cos. Over Teen Addiction
January 23, 2024
W.Va. County To Face Off With Opioid Distributors At 4th Circ.